TS
Theodore R Schroeder
Director

Theodore R Schroeder insider trades: Nabriva Therapeutics (NBRV) stock buys and sales

Director, Nabriva Therapeutics Last trade Dec 28, 2021 122 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2009
8
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Theodore reports to the SEC

and 2 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 28, 2021NBRV↑ Buy$57K
Sep 14, 2021NBRV↑ Buy$56K
Aug 27, 2019NBRV↑ Buy$90K
May 17, 2011CADX↑ Buy$120K
Oct 1, 2010CADX↓ Sell$417K
Jul 1, 2010CADX↓ Sell$350K
Apr 1, 2010CADX↓ Sell$459K
Jan 4, 2010CADX↓ Sell$293K
Oct 16, 2009CADX↓ Sell$214K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Theodore R Schroeder's insider trades

Theodore R Schroeder is a director at Nabriva Therapeutics (NBRV). Since Oct 16, 2009, Theodore has reported 4 open-market purchases worth $323K and 5 sales worth $1.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (60 filings), grants and awards (49 filings), shares returned to the company (4 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBRV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.